Patent ID: 7407962
Filing Date: 2008-08-05
Classification: A61P,C07D

Abstract:
1. A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: A is CR each R is independently selected from hydrogen or an optionally substituted C each R R each y is independently 0-6; each Ar is independently selected from an optionally substituted 5-7 membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an optionally substituted 8-10 membered saturated, partially unsaturated, or fully unsaturated bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; Q is selected from a valence bond, —O—, —S—, —NR—, or a C R each R each R R each w is independently selected from 0-4; and each R optional substituents on one or more unsaturated carbons of an aryl or heteroaryl group are selected from halogen, N optional substituents on an aliphatic group or on a non-aromatic heterocyclic ring are selected from those defined above for the unsaturated carbon of an aryl or heteroaryl group and the following: ═O, ═S, ═NNHR*, ═NN(R*) optional substituents on the nitrogen of a non-aromatic heterocyclic ring are selected from —R